For small, bulky, well-localized infantile hemangiomas, which therapy can be effective?

For small, bulky, well-localized infantile hemangiomas, which therapy can be effective?

• A. Oral propranolol
• B. Intralesional corticosteroids
• C. Laser therapy
• D. Surgical excision

Answer: (B)

For small, bulky, well-localized infantile hemangiomas, delivering therapy directly into the lesion can be highly effective. Intralesional corticosteroids, such as triamcinolone, are injected straight into the hemangioma to produce a local anti-angiogenic and vasoconstrictive effect. This targeted approach slows endothelial proliferation and promotes involution right where the lesion is, yielding good shrinkage with minimal systemic exposure. Oral propranolol works well for many hemangiomas, but it is systemic and carries systemic risks, which may be unnecessary for a small, focal lesion. Laser therapy is helpful for superficial components or residual surface changes, and may not address deeper proliferative tissue. Surgical excision is more invasive and generally avoided if the lesion is still shrinking or if it’s better treated with a localized injection. So, the focused, localized action of intralesional corticosteroids makes them especially suitable for small, bulky, well-localized lesions, offering effective shrinkage with limited systemic effects.

For small, bulky, well-localized infantile hemangiomas, delivering therapy directly into the lesion can be highly effective. Intralesional corticosteroids, such as triamcinolone, are injected straight into the hemangioma to produce a local anti-angiogenic and vasoconstrictive effect. This targeted approach slows endothelial proliferation and promotes involution right where the lesion is, yielding good shrinkage with minimal systemic exposure.

Oral propranolol works well for many hemangiomas, but it is systemic and carries systemic risks, which may be unnecessary for a small, focal lesion. Laser therapy is helpful for superficial components or residual surface changes, and may not address deeper proliferative tissue. Surgical excision is more invasive and generally avoided if the lesion is still shrinking or if it’s better treated with a localized injection.

So, the focused, localized action of intralesional corticosteroids makes them especially suitable for small, bulky, well-localized lesions, offering effective shrinkage with limited systemic effects.